Lilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy ...

Jul 2, 2024 · Eli Lilly on Monday signed a strategic partnership with Radionetics Oncology, which not only provides the pharma with a pipeline of promising cancer radiotherapeutics but also …

CouponFollow Extension

$140
OFF

Radionetics Oncology Enters Into Strategic Agreement With Lilly

4 weeks from now

Jul 1, 2024 · Provides Lilly access to Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals Radionetics to receive $140 million upfront payment Lilly obtains the …

radionetics.com

$1
OFF

Eli Lilly Inks Another Radiopharma Deal, Gaining Option To Buy Startup

4 weeks from now

Jul 1, 2024 · Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 …

biopharmadive.com

$140
OFF

Radionetics Oncology Enters Into Strategic Agreement With Lilly

4 weeks from now

Jul 1, 2024 · Provides Lilly access to Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals Radionetics to receive $140 million upfront payment Lilly obtains the …

businesswire.com

$1
OFF

Lilly Signs Radiopharma Deal With Radionetics, Secures Option To Buy

4 weeks from now

Jul 2, 2024 · In May, Lilly signed a potential $1.1.6 billion deal with Boston-based biotech Aktis Oncology to develop innovative anticancer radiopharmaceuticals using Aktis’ proprietary …

pharmamanufacturing.com

$140
OFF

Eli Lilly And Radionetics Oncology Enter $140m Radiopharma …

4 weeks from now

Jul 2, 2024 · Eli Lilly has agreed to pay Radionetics Oncology $140m upfront to partner on the biotech’s G protein-coupled receptor (GPCR)-targeting small-molecule radiopharmaceuticals. …

pmlive.com

$140
OFF

Eli Lilly Enters $140M Partnership With Radionetics Oncology

4 weeks from now

Jul 4, 2024 · The strategic agreement with Eli Lilly comes shortly after the company’s $52.5 million series A fundraising in February this year. For Eli Lilly, the partnership with Radionetics …

outsourcing-pharma.com

$140
OFF

Radionetics Oncology Announces Strategic Agreement With Eli …

4 weeks from now

Jul 1, 2024 · Under the terms of the agreement, Radionetics received a $140 million up-front cash payment. Additionally, Lilly obtained the exclusive right to acquire Radionetics for $1 billion …

cooley.com

$140
OFF

Radionetics

4 weeks from now

Radionetics provides Lilly access to proprietary GPCR targeting small molecule radiopharmaceuticals. Radionetics receives $140 million upfront payment and Lilly obtains the …

radionetics.com

$140
OFF

Lilly Signs $140M Upfront Partnership With Radionetics In Latest ...

4 weeks from now

Oct 10, 2024 · Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G …

biotech-today.com

$140
OFF

Lilly Builds In Radiopharma With $140m Radionetics Deal

4 weeks from now

4 days ago · Eli Lilly has lined up another deal in the radiopharmaceutical sector, paying $140 million to partner drugs developed by Radionetics Oncology and taking an option on buying …

pharmaphorum.com

$1
OFF

Eli Lilly Inks Deal Worth Over $1.1B To Develop New …

4 weeks from now

May 21, 2024 · Drugmaker Eli Lilly has inked a deal worth over $1 billion to develop new radiopharmaceuticals in concert with biotechnology firm Aktis Oncology. Under terms of the …

radiologybusiness.com

$140
OFF

68Ga-R8760 - Drug Targets, Indications, Patents - Synapse - Patsnap

4 weeks from now

Sep 11, 2023 · The agreement includes a $140 million upfront payment from Lilly as well as the potential right to acquire Radionetics for $1 billion. The companies did not provide specific …

patsnap.com

$1.16
OFF

Lilly Inks Potential $1.16B Deal With Radiopharma Startup

4 weeks from now

May 21, 2024 · Under the agreement, Lilly will take charge of worldwide clinical development and commercialization of the radiopharmaceutical products from phase 1 onwards. In exchange, …

pharmamanufacturing.com

FAQs about Lilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy ... Coupon?

Will Eli Lilly buy radionetics oncology?

Eli Lilly on Monday signed a strategic partnership with Radionetics Oncology, which not only provides the pharma with a pipeline of promising cancer radiotherapeutics but also gives it the exclusive right to buy the San Diego biotech down the line. ...

Why did Lilly acquire radionetics?

Radionetics provides Lilly access to proprietary GPCR targeting small molecule radiopharmaceuticals. Radionetics receives $140 million upfront payment and Lilly obtains the exclusive right to acquire Radionetics for $1 billion. We have a strong sense of purpose and urgency to discover new and innovative cancer treatment options. ...

How much will Lilly pay radionetics?

Lilly will pay Radionetics $140 million upfront for the option rights under the deal, which the companies announced Monday. Radionetics will continue to build its radiopharmaceutical drug pipeline through an “exercise period,” after which Lilly can choose whether to acquire the company. ...

Why is Lilly partnering with radionetics oncology?

"Furthering our commitment to radiopharmaceutical therapies, this relationship provides access to novel GPCR targets and the discovery capabilities of Radionetics Oncology," said Jacob Van Naarden, Executive Vice President and President, Lilly Oncology. ...

What is Lilly doing with radionetics?

The biotech kicked off the Phase I study of 68Ga-R8760 in October 2023 and announced plans to launch clinical programs in breast and lung cancer. For Lilly, Monday’s partnership with Radionetics continues its recent investment spree in the radiopharma space. In October 2023, the pharma snapped up Point Biopharma for $1.4 billion. ...

Where is Eli Lilly headquartered 2024?

A sign bearing Eli Lilly’s logo sits outside of the company’s headquarters on March 17, 2024 in Indianapolis, Indiana. Scott Olson via Getty Images Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 billion. ...